Quantcast
Home > Quotes > QTNT

Quotient Limited Ordinary Shares (QTNT) Quote & Summary Data

QTNT 
$6.9
*  
0.08
1.17%
Get QTNT Alerts
*Delayed - data as of Dec. 12, 2018  -  Find a broker to begin trading QTNT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    QTNT Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 7.2376 / $ 6.85
Share Volume
361,520
50 Day Avg. Daily Volume
279,951
Previous Close
$ 6.82
52 Week High / Low
$ 9.02 / $ 2.78
Market Cap
374,887,702
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
361,520
50 Day Avg. Daily Volume:
279,951

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.99

Trading Range

The current last sale of $6.90 is 148.20% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 7.2376 $ 9.02
 Low: $ 6.85 $ 2.78

Company Description (as filed with the SEC)

We are a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. Our initial focus is on blood grouping and donor disease screening, which is commonly referred to as transfusion diagnostics. Blood grouping involves specific procedures performed at donor or patient testing laboratories to characterize blood, which includes antigen typing and antibody detection. Disease screening involves the screening of donor blood for unwanted pathogens using two different methods, a serological approach (testing for specific antigens or antibodies) and a molecular approach (testing for DNA or RNA). We have over 30 years of experience developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.  ... More ...  


Risk Grade

Where does QTNT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 6.90
Open Date:
Dec. 12, 2018
Close Price:
$ 6.82
Close Date:
Dec. 12, 2018

Consensus Recommendation

Analyst Info